All Case Studies
Pharmaceuticals20 weeks

Swift Pharmaceuticals

GxP compliance requirements not being met by existing IT infrastructure, jeopardizing FDA audit readiness and delaying drug approval timelines.

100%
FDA Audit Ready
99.8%
Data Integrity Score
-30%
Approval Time

The Challenge

GxP compliance requirements not being met by existing IT infrastructure, jeopardizing FDA audit readiness and delaying drug approval timelines.

Our Solution

Byteflu built a GxP-qualified cloud environment on AWS with validated systems, implemented comprehensive audit trails, and established computer system validation (CSV) processes aligned to 21 CFR Part 11 requirements.

Services Deployed

  • Defensible Cybersecurity
  • Cloud Services

Our Approach

Timeline: 20 weeks
  1. 1

    Gap analysis against 21 CFR Part 11 and EU Annex 11 requirements

  2. 2

    Designed and deployed GxP-qualified AWS landing zone with audit logging

  3. 3

    Implemented electronic signatures and immutable audit trails

  4. 4

    Established CSV procedures with IQ/OQ/PQ documentation

  5. 5

    Trained R&D and QA teams on validated system usage and deviation reporting

Want Similar Results?

Let us show you how Byteflu can transform your IT operations.